newsfilter
← Latest News
FDA Approved Drugs·

Approval of Jakafi Xr, Nda #217180 (Type 5 - New Formulation or New Manufacturer)

Approval Date: 05/01/2026; Drug Name: Jakafi Xr, Nda #217180; Active Ingredients: RUXOLITINIB PHOSPHATE; Company: Incyte Corporation; Submission Status: Approval; Submission Classification: Type 5 - New Formulation or New Manufacturer; Application Number: 217180

Company
INCYTE CORPORATION
Keywords
INCYTE CORPORATION